Generic Background Image

Clinical Trial

Neuromodulation and Neurorehabilitation for Treatment of Functional Deficits after mTBI plus PTSD

IRB Protocol Number STU00203773

Contact

Katie Kestner ckestner@sralab.org

Objective

The purpose of this study is to alleviate persisting attention deficits related to mild TBI and PTSD by treating the neurocognitive system of attention.

Who Can Participate

  • Mild TBI/concussive event 3 months to 10 years ago
  • Have co-occuring mild TBI and PTSD

Compensation

Provided

Age Range

18-80

Apply for this Trial

Your information will not be published.

All fields are required.

More Studies

Seeking Research Participants: People with Parkinson's Disease or Multiple Sclerosis

This study aims to understand if remote therapeutic monitoring (RTM) is useful in tracking long term physical activity participation and improving self-efficacy and readiness for exercise. Participants will use their own wearable activity tracker.

read more

Experiences and Outcomes of People Living with SCI: A Mixed Methods, International Collaboration

read more

Intermittent Hypoxia Initiated Motor Plasticity in Individuals With Multiple Sclerosis

read more
view all

Latest Updates

Henry golfing

Watch: How Henry Went from Golf Caddy to Patient to Competitor

Patient Story

FOX 32 Chicago Segment

Shirley Ryan AbilityLab Research Scientist and Patient Featured in FOX 32 Chicago Segment About Self-Driving Wheelchair Technology

News

Doug walking his dog

Shirley Ryan AbilityLab Patient and Physician Featured in AARP Article on Stroke Recovery

News

view all